Literature DB >> 8642333

Antigen-induced generation of lyso-phospholipids in human airways.

F H Chilton1, F J Averill, W C Hubbard, A N Fonteh, M Triggiani, M C Liu.   

Abstract

The goal of the current study was to examine the formation of phospholipids, 1-radyl-2-lysosn-glycero-phospholipids (lyso-PL) and 2-acetylated phospholipids (such as PAF) as well as mechanisms responsible for generating these phospholipids in bronchoalveolar lavage fluid (BAI.F) from allergic subjects challenged with antigen. Bronchoalveolar lavage was performed in normal and allergic subjects before, 5-30 min, 6 h, and 20 h after segmental antigen challenge via a wedged bronchoscope. Levels of 1-hexadecyl-2-lyso-phospholipids and 1-hexadecyl-2-acetyl-phospholipids were initially determined by negative ion chemical ionization gas chromatography/mass spectrometry (NICI-GC/MS). Antigen dramatically elevated quantities of 1-hexadecyl-2-lyso-phospholipids in allergic subjects 20 h after challenge when compared to non-allergic controls. In contrast, there was not a significant increase in levels of 1-hexadecyl-2-acetyl-phospholipids after antigen challenge. Closer examination of 1-radyl-2-lyso-sn-glycero-3-phosphocholine (GPC) revealed that 1-palmitoyl-2-lyso-GPC, 1-myristoyl-2-lyso-GPC and 1-hexadecyl-2-lyso-GPC were three major molecular species produced after antigen challenge. 1-palmitoyl-2-lyso-GPC increased sevenfold to levels of 222 +/- 75 ng/ml of BALF 20 h after antigen challenge. The elevated levels of lyso-PL correlated with levels of albumin used to assess plasma exudation induced by allergen challenge. In contrast, the time course of prostaglandin D2 (PGD2) or 9 alpha, 11 beta PGF2 (11 beta PGF2) formation did not correlate with lyso-PL generation. To examine the mechanism leading to lyso-phospholipid formation in antigen-challenged allergic subjects, secretory phospholipase A2 (PI.A2) and acetyl hydrolase activities were measured. There was a significant increase in PLA2 activity found in BALF of allergic subjects challenged with antigen when compared to saline controls. This activity was neutralized by an antibody directed against low molecular mass, (14 kD) human synovial PLA2 and dithiothreitol. Acetyl hydrolase activity also markedly increased in BALF obtained after antigen challenge. This study indicates that high levels of lyso-PLs are present in airways of allergic subjects challenged with antigen and provides evidence for two distinct mechanisms that could induce lyso-PL formation. Future studies will be necessary to determine the ramifications of these high levels of lyso-phospholipids on airway function.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8642333      PMCID: PMC2192563          DOI: 10.1084/jem.183.5.2235

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  64 in total

1.  Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution.

Authors:  S I Rennard; G Basset; D Lecossier; K M O'Donnell; P Pinkston; P G Martin; R G Crystal
Journal:  J Appl Physiol (1985)       Date:  1986-02

2.  Airway hyperresponsiveness induced by platelet-activating factor: role of thromboxane generation.

Authors:  K F Chung; H Aizawa; G D Leikauf; I F Ueki; T W Evans; J A Nadel
Journal:  J Pharmacol Exp Ther       Date:  1986-03       Impact factor: 4.030

3.  1-O-alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine. A common source of platelet-activating factor and arachidonate in human polymorphonuclear leukocytes.

Authors:  F H Chilton; J M Ellis; S C Olson; R L Wykle
Journal:  J Biol Chem       Date:  1984-10-10       Impact factor: 5.157

4.  Human serum acid-labile factor is an acylhydrolase that inactivates platelet-activating factor.

Authors:  R S Farr; M L Wardlow; C P Cox; K E Meng; D E Greene
Journal:  Fed Proc       Date:  1983-11

5.  Excretion of platelet activating factor-acetylhydrolase and phospholipase A2 into nasal fluids after allergenic challenge: possible role in the regulation of platelet activating factor release.

Authors:  L Touqui; N Herpin-Richard; R M Gene; E Jullian; D Aljabi; C Hamberger; B B Vargaftig; J F Dessange
Journal:  J Allergy Clin Immunol       Date:  1994-07       Impact factor: 10.793

6.  Measurement of sub-picogram quantities of platelet activating factor (AGEPC) by gas chromatography/negative ion chemical ionization mass spectrometry.

Authors:  C S Ramesha; W C Pickett
Journal:  Biomed Environ Mass Spectrom       Date:  1986-03

7.  Antigen-initiated release of platelet-activating factor (PAF-acether) from mouse bone marrow-derived mast cells sensitized with monoclonal IgE.

Authors:  J M Mencia-Huerta; R A Lewis; E Razin; K F Austen
Journal:  J Immunol       Date:  1983-12       Impact factor: 5.422

8.  Airway responses to sequential challenges with platelet-activating factor and leukotriene D4 in rhesus monkeys.

Authors:  R Patterson; P R Bernstein; K E Harris; R D Krell
Journal:  J Lab Clin Med       Date:  1984-09

9.  Phospholipase A2 activity in sera and synovial fluids in rheumatoid arthritis and osteoarthritis. Its possible role as a proinflammatory enzyme.

Authors:  W Pruzanski; P Vadas; E Stefanski; M B Urowitz
Journal:  J Rheumatol       Date:  1985-04       Impact factor: 4.666

10.  Lysophosphatidylcholine increases airway and capillary permeability in the isolated perfused rat lung.

Authors:  M Lindahl; A R Hede; C Tagesson
Journal:  Exp Lung Res       Date:  1986       Impact factor: 2.459

View more
  34 in total

1.  Eosinophil cysteinyl leukotriene synthesis mediated by exogenous secreted phospholipase A2 group X.

Authors:  Ying Lai; Rob C Oslund; James G Bollinger; William R Henderson; Luis F Santana; William A Altemeier; Michael H Gelb; Teal S Hallstrand
Journal:  J Biol Chem       Date:  2010-10-25       Impact factor: 5.157

2.  Group V secretory phospholipase A2 is involved in macrophage activation and is sufficient for macrophage effector functions in allergic pulmonary inflammation.

Authors:  Shin Ohta; Mitsuru Imamura; Wei Xing; Joshua A Boyce; Barbara Balestrieri
Journal:  J Immunol       Date:  2013-05-06       Impact factor: 5.422

Review 3.  Advancements in understanding the role of lysophospholipids and their receptors in lung disorders including bronchopulmonary dysplasia.

Authors:  Tara Sudhadevi; Alison W Ha; David L Ebenezer; Panfeng Fu; Vijay Putherickal; Viswanathan Natarajan; Anantha Harijith
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2020-03-10       Impact factor: 4.698

4.  Secreted Phospholipase A2 Group X Acts as an Adjuvant for Type 2 Inflammation, Leading to an Allergen-Specific Immune Response in the Lung.

Authors:  Herbert Luke Ogden; Ying Lai; James D Nolin; Dowon An; Charles W Frevert; Michael H Gelb; William A Altemeier; Teal S Hallstrand
Journal:  J Immunol       Date:  2020-04-27       Impact factor: 5.422

5.  Blockade of human group X secreted phospholipase A2 (GX-sPLA2)-induced airway inflammation and hyperresponsiveness in a mouse asthma model by a selective GX-sPLA2 inhibitor.

Authors:  William R Henderson; Rob C Oslund; James G Bollinger; Xin Ye; Ying-Tzang Tien; Jun Xue; Michael H Gelb
Journal:  J Biol Chem       Date:  2011-06-07       Impact factor: 5.157

Review 6.  Epithelial regulation of eicosanoid production in asthma.

Authors:  Teal S Hallstrand; Ying Lai; William R Henderson; William A Altemeier; Michael H Gelb
Journal:  Pulm Pharmacol Ther       Date:  2012-12       Impact factor: 3.410

Review 7.  Lysophosphatidic acid signaling in airway epithelium: role in airway inflammation and remodeling.

Authors:  Yutong Zhao; Viswanathan Natarajan
Journal:  Cell Signal       Date:  2008-10-26       Impact factor: 4.315

8.  Molecular basis of phospholipase A2 activity toward phospholipids with sn-1 substitutions.

Authors:  Lars Linderoth; Thomas L Andresen; Kent Jørgensen; Robert Madsen; Günther H Peters
Journal:  Biophys J       Date:  2007-09-07       Impact factor: 4.033

9.  Regulation and function of epithelial secreted phospholipase A2 group X in asthma.

Authors:  Teal S Hallstrand; Ying Lai; William A Altemeier; Cara L Appel; Brian Johnson; Charles W Frevert; Kelly L Hudkins; James G Bollinger; Prescott G Woodruff; Dallas M Hyde; William R Henderson; Michael H Gelb
Journal:  Am J Respir Crit Care Med       Date:  2013-07-01       Impact factor: 21.405

10.  Role of lysophosphatidic acid receptor LPA2 in the development of allergic airway inflammation in a murine model of asthma.

Authors:  Yutong Zhao; Jiankun Tong; Donghong He; Srikanth Pendyala; Berdyshev Evgeny; Jerold Chun; Anne I Sperling; Viswanathan Natarajan
Journal:  Respir Res       Date:  2009-11-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.